A conference abstract (not a published paper) presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2022 compares the … read more
Results of the phase 3 trial of lecanemab for early Alzheimer’s disease has been published in New England Journal of … read more
Dementia research is at a tipping point. Earlier this year, an Alzheimer’s drug, Eisai’s lecanemab, demonstrated a small but clear … read more
A study published in JAMA Network Open looks at the development of a clinical risk score prediction tool for dementia. … read more
Roche have announced that the results of their phase 3 trial evaluating gantenerumab in people with early Alzheimer’s disease did … read more
A study published in the Journal of Alzheimer’s Disease looks at soluble amyloid-beta, amyloid plaques, and cognition in people with … read more
A press release from Eisai and Biogen has announced positive topline results from their Phase 3 clinical trial of lecanemab … read more
A study published in PLOS Genetics looks at the use of a genetic risk score for Alzheimer’s disease. Dr … read more
A cell study published in Journal of Alzheimer’s Disease looks at the potential involvement of varicella zoster virus (VSV) in … read more
A study, published in the Journal of Neurology Neurosurgery & Psychiatry, looked at the evidence of whether noradrenergic drugs may … read more
A study published in Communications Medicine looks at the use of an MRI brain scan and predictive modelling to detect … read more
A study published in Nature Genetics provides new insights into the genetic cause of Alzheimer’s disease. Dr Susan Kohlhaas, … read more
A study published in Nature Aging identifies sildenafil as a candidate drug for Alzheimer’s disease. Prof Tara Spires-Jones, Deputy Director … read more
Biogen have announced an update on the regulatory review of aducanumab in the European Union. Dr Richard Oakley, Associate Director … read more
A study in mice published in Molecular Psychiatry investigates a potential vaccine against Alzheimer’s disease. Prof Carol Brayne, Professor … read more
A study published in Science Advances looks at tau seed accumulation in Alzheimer’s disease. Prof Tara Spires-Jones, UK Dementia … read more
A study published in Brain looks at a genetic link between risk for Alzheimer’s disease and severe COVID-19 outcomes via … read more
A study published in Neuropsychopharmacology uses UK Biobank data to look at association between polygenic risk for Alzheimer’s disease, brain … read more
Research, published in PLOS Biology, has looked at liver protein a-beta and Alzheimer’s. Prof Tara Spires-Jones, UK Dementia Research Institute … read more
The U.S. Food & Drug Administration (FDA) has today approved aducanumab (Aduhelm) to treat patients with Alzheimer’s disease. Prof … read more
